175 related articles for article (PubMed ID: 21957232)
1. In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function.
Cheng N; Cai H; Belluscio L
J Neurosci; 2011 Sep; 31(39):13699-704. PubMed ID: 21957232
[TBL] [Abstract][Full Text] [Related]
2. APP Overexpression Causes Aβ-Independent Neuronal Death through Intrinsic Apoptosis Pathway.
Cheng N; Jiao S; Gumaste A; Bai L; Belluscio L
eNeuro; 2016; 3(4):. PubMed ID: 27517085
[TBL] [Abstract][Full Text] [Related]
3. Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer's disease model.
Cheng N; Bai L; Steuer E; Belluscio L
J Neurosci; 2013 Jul; 33(30):12208-17. PubMed ID: 23884929
[TBL] [Abstract][Full Text] [Related]
4. Laminar specific detection of APP induced neurodegeneration and recovery using MEMRI in an olfactory based Alzheimer's disease mouse model.
Saar G; Cheng N; Belluscio L; Koretsky AP
Neuroimage; 2015 Sep; 118():183-92. PubMed ID: 26021215
[TBL] [Abstract][Full Text] [Related]
5. Progressive Spread of Beta-amyloid Pathology in an Olfactory-driven Amyloid Precursor Protein Mouse Model.
Murray HC; Saar G; Bai L; Bouraoud N; Dodd S; Highet B; Ryan B; Curtis MA; Koretsky A; Belluscio L
Neuroscience; 2023 Apr; 516():113-124. PubMed ID: 36716914
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
[TBL] [Abstract][Full Text] [Related]
7. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
[TBL] [Abstract][Full Text] [Related]
8. Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain.
Heiland T; Zeitschel U; Puchades MA; Kuhn PH; Lichtenthaler SF; Bjaalie JG; Hartlage-Rübsamen M; Roßner S; Höfling C
Glia; 2019 Feb; 67(2):393-403. PubMed ID: 30485540
[TBL] [Abstract][Full Text] [Related]
9. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice.
Mucke L; Masliah E; Johnson WB; Ruppe MD; Alford M; Rockenstein EM; Forss-Petter S; Pietropaolo M; Mallory M; Abraham CR
Brain Res; 1994 Dec; 666(2):151-67. PubMed ID: 7882025
[TBL] [Abstract][Full Text] [Related]
10. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.
Wyss-Coray T; Yan F; Lin AH; Lambris JD; Alexander JJ; Quigg RJ; Masliah E
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10837-42. PubMed ID: 12119423
[TBL] [Abstract][Full Text] [Related]
11. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
13. High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease.
Rockenstein E; Mante M; Alford M; Adame A; Crews L; Hashimoto M; Esposito L; Mucke L; Masliah E
J Biol Chem; 2005 Sep; 280(38):32957-67. PubMed ID: 16027115
[TBL] [Abstract][Full Text] [Related]
14. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.
Rockenstein EM; McConlogue L; Tan H; Power M; Masliah E; Mucke L
J Biol Chem; 1995 Nov; 270(47):28257-67. PubMed ID: 7499323
[TBL] [Abstract][Full Text] [Related]
15. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice.
O'Neil JN; Mouton PR; Tizabi Y; Ottinger MA; Lei DL; Ingram DK; Manaye KF
J Chem Neuroanat; 2007 Nov; 34(3-4):102-7. PubMed ID: 17658239
[TBL] [Abstract][Full Text] [Related]
16. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
[TBL] [Abstract][Full Text] [Related]
18. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
19. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic and neuroprotective effects of hAPP in transgenic mice.
Mucke L; Abraham CR; Masliah E
Ann N Y Acad Sci; 1996 Jan; 777():82-8. PubMed ID: 8624131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
